A Phase 1, Randomized, Double-blind, Single-dose Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of AMG 145 in Healthy Chinese Subjects

Sponsor ID

20120134

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

Phase

Phase 1

Product

Evolocumab

Type

Interventional

Masking

N/A

Enrollment

N/A

Additional Study Details

Primary Outcome Measures

Not Available

Secondary Outcome Measures

Not Available

Study Synopsis

Available Language(s): English

Location

Status

Location

Research Site

Shanghai, Shanghai, China, 200032

Status

Completed